32
https://pubmed.ncbi.nlm.nih.gov/38093123
The abstract reports that a new dipeptide mimetic, GTS-301, shows potential as an antidiabetic drug by reducing hyperglycemia and polydipsia in a streptozotocin-induced diabetes model in mice, supporting the concept of similar neurochemical mechanisms regulating neurons and β-cells.
